marketcaparena
Search

    CRIS

    CURIS INC

    Company overview

    Market capitalization
    $1.74M
    Employees
    20
    Latest publication
    2026-09-29
    About CURIS INC

    Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma; CA-170, an oral, small-molecule antagonist designated as CA-170 that selectively targets PD-L1 and VISTA; and CA-327, an oral, small molecule, TIM3/PD-L1, which is a molecule antagonist of PD-L1 and TIM3. It has collaboration agreements with Genentech Inc., or Genentech and F. Hoffmann-La Roche Ltd, or Roche, for the commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway antagonist for the treatment of advanced basal cell carcinoma, or BCC; Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology; and also licensed three programs under the Aurigene collaboration, including emavusertib. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue0USD0USD1,138,000USD3,176,000USD2,749,000USD2,380,000USD3,345,000USD2,931,000USD
    Cost Of Revenue0USD8,000USD36,000USD15,000USD16,000USD14,000USD17,000USD22,000USD
    Gross Profit0USD-8,000USD1,138,000USD3,161,000USD2,733,000USD2,366,000USD3,328,000USD2,909,000USD
    Research Development6,714,000USD6,449,000USD5,825,000USD6,432,000USD7,458,000USD8,539,000USD8,968,000USD9,723,000USD
    Selling General Administrative3,226,000USD5,070,000USD2,883,000USD3,653,000USD3,526,000USD3,984,000USD3,354,000USD3,753,000USD
    General And Administrative Expenses3,226,000USD———————
    Total Operating Expenses9,940,000USD11,511,000USD8,708,000USD10,085,000USD10,984,000USD12,523,000USD12,322,000USD13,476,000USD
    Operating Income-9,940,000USD-11,519,000USD-7,570,000USD-6,924,000USD-8,251,000USD-10,157,000USD-8,994,000USD-10,567,000USD
    Total Other Income Expense Net1,359,000USD-12,680,000USD26,926,000USD-805,000USD-342,000USD-459,000USD-624,000USD475,000USD
    Interest Income62,000USD77,000USD51,000USD80,000USD92,000USD93,000USD227,000USD325,000USD
    Net Income-8,581,000USD-24,199,000USD19,356,000USD-7,729,000USD-8,593,000USD-10,616,000USD-9,618,000USD-10,092,000USD
    Net Interest Income—77,000USD-2,134,000USD80,000USD92,000USD93,000USD-388,000USD325,000USD
    Income Before Tax—-24,199,000USD19,356,000USD-7,729,000USD-8,593,000USD-10,616,000USD-9,618,000USD-10,092,000USD
    Net Income From Continuing Ops—-24,199,000USD19,356,000USD-7,729,000USD-8,593,000USD-10,616,000USD-9,618,000USD-10,092,000USD
    Ebit—-24,199,000USD19,935,000USD-7,729,000USD-8,593,000USD-10,616,000USD-7,226,000USD-10,092,000USD
    Ebitda—-24,191,000USD19,971,000USD-7,687,000USD-8,551,000USD-10,557,000USD-7,210,000USD-10,031,000USD
    Depreciation And Amortization—8,000USD36,000USD42,000USD42,000USD59,000USD16,000USD61,000USD
    Reconciled Depreciation—8,000USD36,000USD32,000USD42,000USD59,000USD16,000USD61,000USD
    Interest Expense——314,000USD———615,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20182018-12-31 · USDFY 19991999-12-31 · USD
    Total Revenue9,443,000USD10,908,000USD10,023,000USD10,162,000USD10,428,000USD3,211,860USD
    Cost Of Revenue45,000USD98,000USD229,000USD257,000USD563,000USD—
    Gross Profit9,398,000USD10,810,000USD10,023,000USD9,905,000USD9,865,000USD3,211,860USD
    Research Development28,254,000USD38,562,000USD39,496,000USD43,277,000USD24,413,000USD10,434,560USD
    Selling General Administrative14,046,000USD16,790,000USD18,647,000USD19,648,000USD14,785,000USD5,524,077USD
    Total Operating Expenses42,345,000USD55,352,000USD58,355,000USD62,925,000USD39,198,000USD17,086,355USD
    Operating Income-32,902,000USD-44,542,000USD-48,332,000USD-53,020,000USD-29,333,000USD-13,874,495USD
    Interest Income316,000USD1,768,000USD2,815,000USD1,119,000USD684,000USD—
    Interest Expense2,185,000USD615,000USD2,019,000USD4,771,000USD3,926,000USD0USD
    Net Interest Income-1,869,000USD1,153,000USD-1,956,000USD-3,652,000USD-3,242,000USD—
    Income Before Tax-7,582,000USD-43,389,000USD-47,413,000USD-56,672,000USD-32,575,000USD-13,872,718USD
    Net Income-7,582,000USD-43,389,000USD-47,413,000USD-60,324,000USD-32,575,000USD-12,109,790USD
    Net Income From Continuing Ops-7,582,000USD-43,389,000USD-47,030,000USD-56,672,000USD-32,575,000USD—
    Ebit-5,397,000USD-42,774,000USD-48,332,000USD-53,020,000USD-28,649,000USD-13,874,495USD
    Ebitda-5,228,000USD-42,571,000USD-48,332,000USD-52,787,000USD-28,472,000USD-12,885,005USD
    Depreciation And Amortization169,000USD203,000USD255,000USD233,000USD177,000USD989,490USD
    Reconciled Depreciation169,000USD203,000USD283,000USD233,000USD177,000USD—
    Total Other Income Expense Net25,320,000USD1,153,000USD919,000USD-3,652,000USD-3,242,000USD1,777USD
    Income Tax Expense——-255,000USD3,652,000USD683,000USD-1,764,705USD
    Non Operating Income Net Other———-3,652,000USD-3,242,000USD—
    Net Income Applicable To Common Shares———-56,672,000USD-32,600,000USD—
    Unclassified Operating Expenses—————1,127,718USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets18,970,000USD29,686,000USD19,966,000USD27,641,000USD29,234,000USD39,326,000USD41,265,000USD42,473,000USD
    Cash And Equivalents5,073,000USD———————
    Total Current Assets6,724,000USD15,001,000USD6,915,000USD13,907,000USD14,419,000USD24,811,000USD26,385,000USD26,937,000USD
    Other Current Assets1,107,000USD1,610,000USD1,854,000USD1,613,000USD1,529,000USD2,214,000USD3,039,000USD3,105,000USD
    Other Non Current Assets2,012,000USD———————
    Total Liabilities14,275,000USD———————
    Total Current Liabilities13,675,000USD14,974,000USD14,076,000USD19,912,000USD19,372,000USD20,117,000USD19,027,000USD22,034,000USD
    Other Current Liabilities7,243,000USD———————
    Total Stockholder Equity4,695,000USD12,707,000USD5,462,000USD-14,691,000USD-13,986,000USD-6,607,000USD-5,998,000USD-8,735,000USD
    Total Equity Including Noncontrolling Interest4,695,000USD———————
    Property Plant Equipment Net1,252,000USD2,943,000USD1,952,000USD2,319,000USD2,673,000USD3,029,000USD3,394,000USD3,707,000USD
    Goodwill8,982,000USD———————
    Accounts Payable5,388,000USD6,742,000USD5,612,000USD4,445,000USD4,097,000USD5,104,000USD3,024,000USD3,818,000USD
    Short Term Debt1,044,000USD1,229,000USD1,190,000USD1,228,000USD1,265,000USD1,301,000USD1,336,000USD1,292,000USD
    Common Stock19,000USD400,000USD129,000USD127,000USD107,000USD105,000USD85,000USD60,000USD
    Retained Earnings-1,280,161,000USD-1,271,580,000USD-1,247,381,000USD-1,266,737,000USD-1,259,008,000USD-1,250,415,000USD-1,239,799,000USD-1,230,181,000USD
    Total Liab—16,979,000USD14,504,000USD42,332,000USD43,220,000USD45,933,000USD47,263,000USD51,208,000USD
    Other Current Liab—7,003,000USD7,274,000USD14,239,000USD14,010,000USD13,712,000USD14,667,000USD16,924,000USD
    Capital Stock—400,000USD129,000USD127,000USD107,000USD105,000USD85,000USD60,000USD
    Good Will—8,982,000USD8,982,000USD8,982,000USD8,982,000USD8,982,000USD8,982,000USD8,982,000USD
    Other Assets—2,760,000USD2,353,000USD———-863,000USD—
    Cash—15,001,000USD5,061,000USD9,051,000USD10,138,000USD20,282,000USD19,997,000USD20,854,000USD
    Cash And Short Term Investments—15,001,000USD5,061,000USD9,051,000USD10,138,000USD20,282,000USD19,997,000USD20,854,000USD
    Net Debt—-13,664,000USD-3,443,000USD-7,083,000USD-7,829,000USD-17,643,000USD-17,043,000USD-17,594,000USD
    Short Long Term Debt Total—1,337,000USD1,618,000USD1,968,000USD2,309,000USD2,639,000USD2,954,000USD3,260,000USD
    Property Plant Equipment Gross—1,606,000USD2,803,000USD2,319,000USD2,673,000USD3,029,000USD4,407,000USD3,707,000USD
    Common Stock Shares Outstanding—968,173shares787,353shares784,008shares631,382shares424,694shares383,561shares297,046shares
    Non Current Assets Total—11,925,000USD13,051,000USD13,734,000USD14,815,000USD14,515,000USD14,880,000USD15,536,000USD
    Non Current Liabilities Total—2,005,000USD428,000USD22,420,000USD23,848,000USD25,816,000USD28,236,000USD29,174,000USD
    Non Currrent Assets Other—-544,000USD2,117,000USD2,433,000USD2,616,000USD1,960,000USD2,504,000USD2,847,000USD
    Net Working Capital—1,637,000USD-7,161,000USD-6,005,000USD-4,953,000USD4,694,000USD7,358,000USD4,903,000USD
    Unclassified Current Assets—-1,610,000USD——————
    Unclassified Non Current Assets—-2,760,000USD-2,353,000USD—————
    Unclassified Non Current Liabilities—2,005,000USD——1,044,000USD1,338,000USD1,618,000USD1,968,000USD
    Unclassified Equity—1,283,487,000USD1,252,585,000USD1,251,792,000USD1,244,808,000USD1,243,598,000USD1,233,631,000USD1,221,326,000USD
    Net Receivables——0USD3,243,000USD2,752,000USD2,315,000USD3,349,000USD2,978,000USD
    Non Current Liabilities Other———21,680,000USD22,804,000USD24,478,000USD26,618,000USD27,206,000USD
    Short Term Investments——————0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets19,966,000USD41,265,000USD77,282,000USD108,848,000USD162,301,000USD204,358,000USD35,107,000USD37,365,000USD
    Other Current Assets1,854,000USD3,039,000USD1,780,000USD3,521,000USD3,267,000USD1,215,000USD1,216,000USD827,000USD
    Total Liab14,504,000USD47,263,000USD57,612,000USD62,296,000USD71,594,000USD73,688,000USD69,018,000USD41,861,000USD
    Total Stockholder Equity5,462,000USD-5,998,000USD19,670,000USD46,552,000USD90,707,000USD130,670,000USD-33,911,000USD-4,496,000USD
    Other Current Liab7,274,000USD14,667,000USD17,544,000USD5,679,000USD6,339,000USD3,625,000USD1,910,000USD3,457,000USD
    Common Stock129,000USD85,000USD59,000USD966,000USD916,000USD915,000USD332,000USD332,000USD
    Capital Stock129,000USD85,000USD59,000USD966,000USD916,000USD915,000USD332,000USD332,000USD
    Retained Earnings-1,247,381,000USD-1,239,799,000USD-1,196,410,000USD-1,148,997,000USD-1,092,325,000USD-1,046,889,000USD-1,016,981,000USD-984,840,000USD
    Good Will8,982,000USD8,982,000USD8,982,000USD8,982,000USD8,982,000USD8,982,000USD8,982,000USD8,982,000USD
    Other Assets2,353,000USD——2,657,000USD726,000USD21,961,000USD819,000USD155,000USD
    Cash5,061,000USD19,997,000USD26,681,000USD19,658,000USD40,014,000USD129,610,000USD15,430,000USD23,636,000USD
    Cash And Short Term Investments5,061,000USD19,997,000USD56,334,000USD85,623,000USD115,884,000USD168,494,000USD20,543,000USD24,270,000USD
    Total Current Assets6,915,000USD26,385,000USD60,908,000USD89,233,000USD122,375,000USD172,752,000USD25,003,000USD27,134,000USD
    Total Current Liabilities14,076,000USD19,027,000USD22,021,000USD12,813,000USD13,438,000USD10,079,000USD6,541,000USD6,377,000USD
    Net Debt-3,443,000USD-17,043,000USD-23,887,000USD-12,917,000USD-34,974,000USD-121,948,000USD-15,264,000USD11,848,000USD
    Short Term Debt1,190,000USD1,336,000USD1,305,000USD3,941,000USD682,000USD2,288,000USD166,000USD6,884,000USD
    Short Long Term Debt Total1,618,000USD2,954,000USD2,794,000USD6,741,000USD5,040,000USD7,662,000USD166,000USD35,484,000USD
    Net Receivables0USD3,349,000USD2,794,000USD2,975,000USD3,224,000USD3,043,000USD3,244,000USD2,864,000USD
    Accounts Payable5,612,000USD3,024,000USD3,172,000USD3,193,000USD6,417,000USD4,166,000USD4,465,000USD2,909,000USD
    Property Plant Equipment Net1,952,000USD3,394,000USD3,490,000USD5,090,000USD6,254,000USD7,241,000USD303,000USD267,000USD
    Property Plant Equipment Gross2,803,000USD4,407,000USD5,481,000USD5,090,000USD6,254,000USD7,241,000USD303,000USD267,000USD
    Common Stock Shares Outstanding658,201shares315,314shares264,664shares4,669,625shares228,922shares121,675shares82,951shares82,795shares
    Non Current Assets Total13,051,000USD14,880,000USD16,374,000USD19,615,000USD39,926,000USD31,606,000USD10,104,000USD10,231,000USD
    Non Current Liabilities Total428,000USD28,236,000USD35,591,000USD49,483,000USD58,156,000USD63,609,000USD62,477,000USD35,484,000USD
    Non Currrent Assets Other2,117,000USD1,960,000USD3,902,000USD3,711,000USD726,000USD819,000USD819,000USD982,000USD
    Net Working Capital-7,161,000USD7,358,000USD47,391,000USD82,106,000USD108,937,000USD162,673,000USD18,462,000USD14,711,000USD
    Unclassified Non Current Assets-2,353,000USD————-21,961,000USD——
    Unclassified Equity1,252,585,000USD1,233,631,000USD1,215,733,000USD1,193,803,000USD1,181,309,000USD1,175,732,000USD984,493,000USD981,705,000USD
    Short Term Investments—0USD29,653,000USD65,965,000USD75,870,000USD38,884,000USD5,113,000USD634,000USD
    Non Current Liabilities Other—26,618,000USD42,606,000USD52,283,000USD58,156,000USD58,235,000USD62,477,000USD11,000USD
    Unclassified Non Current Liabilities—1,618,000USD-7,015,000USD-52,283,000USD-53,798,000USD-53,195,000USD-62,477,000USD6,862,000USD
    Inventory——-2,886,000USD-2,886,000USD-2,541,000USD-399,000USD-94,000USD-827,000USD
    Accumulated Other Comprehensive Income——229,000USD-186,000USD-109,000USD-3,000USD-2,087,000USD-2,025,000USD
    Other Liab———49,483,000USD53,798,000USD58,235,000USD62,477,000USD11,000USD
    Long Term Investments———0USD23,964,000USD14,564,000USD—153,000USD
    Net Tangible Assets———37,570,000USD81,725,000USD121,688,000USD-42,893,000USD-13,496,000USD
    Unclassified Current Assets———-2,886,000USD————
    Short Long Term Debt—————557,000USD—6,884,000USD
    Long Term Debt—————334,000USD—28,600,000USD
    Current Deferred Revenue———————-6,873,000USD
    Unclassified Current Liabilities———————-13,757,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation16,000USD
    Stock Based Compensation1,144,000USD
    Change To Account Receivables0USD
    Change To Liabilities-311,000USD
    Change In Working Capital-3,000USD
    Operating Cash Flow-18,647,000USD
    Investing Cash Flow0USD
    Financing Cash Flow18,659,000USD
    Change In Cash12,000USD
    End Cash Flow5,617,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-24,199,000USD19,356,000USD-7,729,000USD-8,593,000USD-10,616,000USD-9,618,000USD-10,092,000USD-11,803,000USD
    Depreciation8,000USD36,000USD32,000USD42,000USD59,000USD16,000USD61,000USD62,000USD
    Stock Based Compensation575,000USD795,000USD924,000USD1,135,000USD1,164,000USD1,280,000USD1,384,000USD1,704,000USD
    Other Non Cash Items15,076,000USD-26,542,000USD363,000USD316,000USD307,000USD1,114,000USD147,000USD-209,000USD
    Change To Account Receivables0USD-1,138,000USD-491,000USD-437,000USD1,034,000USD-371,000USD-432,000USD-392,000USD
    Change In Working Capital114,000USD-16,000USD841,000USD-909,000USD1,834,000USD-2,052,000USD2,564,000USD-889,000USD
    Total Cash From Operating Activities-9,001,000USD-6,371,000USD-5,569,000USD-8,009,000USD-7,252,000USD-9,260,000USD-5,936,000USD-11,135,000USD
    Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
    Free Cash Flow-9,001,000USD-6,371,000USD-5,569,000USD-8,009,000USD-7,252,000USD-9,260,000USD-5,936,000USD-11,135,000USD
    Total Cash From Financing Activities18,941,000USD-119,000USD4,482,000USD-2,135,000USD7,537,000USD8,831,000USD-1,524,000USD-1,464,000USD
    Issuance Of Capital Stock18,941,000USD-119,000USD6,049,000USD-578,000USD10,000,000USD11,036,000USD696,000USD291,000USD
    Change In Cash9,940,000USD-3,990,000USD-1,087,000USD-10,144,000USD285,000USD-857,000USD10,858,000USD-19,960,000USD
    Begin Period Cash Flow5,061,000USD9,595,000USD10,138,000USD20,282,000USD19,997,000USD21,398,000USD9,996,000USD29,956,000USD
    End Period Cash Flow15,001,000USD5,605,000USD9,051,000USD10,138,000USD20,282,000USD20,541,000USD20,854,000USD9,996,000USD
    Other Cashflows From Financing Activities18,941,000USD-119,000USD4,482,000USD-1,557,000USD-2,463,000USD-2,205,000USD-2,220,000USD-1,755,000USD
    Unclassified Financing Cash Flow-18,941,000USD—-6,049,000USD—————
    Investments—0USD0USD0USD0USD-428,000USD18,318,000USD-7,361,000USD
    Total Cashflows From Investing Activities—2,500,000USD———-428,000USD18,318,000USD-7,361,000USD
    Other Cashflows From Investing Activities—2,500,000USD——————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Net Income-7,582,000USD-43,389,000USD-47,413,000USD-45,436,000USD-29,908,000USD-32,141,000USD-32,575,000USD-53,317,000USD
    Depreciation169,000USD187,000USD255,000USD158,000USD144,000USD125,000USD177,000USD235,000USD
    Stock Based Compensation4,018,000USD5,927,000USD6,000,000USD5,279,000USD2,698,000USD2,658,000USD3,940,000USD5,359,000USD
    Other Non Cash Items-25,556,000USD1,428,000USD-55,000USD-26,000USD255,000USD4,711,000USD-112,000USD91,000USD
    Change To Account Receivables-1,032,000USD-555,000USD181,000USD-181,000USD201,000USD-380,000USD209,000USD-614,000USD
    Change In Working Capital1,750,000USD-3,716,000USD2,779,000USD1,004,000USD1,048,000USD-1,558,000USD-1,502,000USD-723,000USD
    Total Cash From Operating Activities-27,201,000USD-39,563,000USD-38,434,000USD-37,619,000USD-25,739,000USD-26,205,000USD-30,065,000USD-48,355,000USD
    Capital Expenditures0USD0USD-416,000USD-416,000USD-677,000USD-41,000USD-85,000USD-188,000USD
    Free Cash Flow-27,201,000USD-39,563,000USD-38,434,000USD-37,619,000USD-26,416,000USD-26,246,000USD-30,150,000USD-48,543,000USD
    Investments0USD29,442,000USD26,732,000USD-47,895,000USD-49,048,000USD-4,415,000USD21,459,000USD-3,442,000USD
    Total Cashflows From Investing Activities2,500,000USD29,442,000USD37,786,000USD-47,895,000USD-49,048,000USD-4,456,000USD21,374,000USD-3,630,000USD
    Total Cash From Financing Activities9,765,000USD3,437,000USD7,580,000USD-4,172,000USD188,814,000USD23,271,000USD-5,961,000USD64,235,000USD
    Issuance Of Capital Stock15,352,000USD12,023,000USD13,745,000USD165,612,000USD193,222,000USD—0USD—
    Change In Cash-14,936,000USD-6,684,000USD6,932,000USD-89,686,000USD114,027,000USD-8,053,000USD-14,652,000USD12,250,000USD
    Begin Period Cash Flow20,541,000USD27,225,000USD20,293,000USD130,426,000USD16,399,000USD23,636,000USD38,288,000USD26,038,000USD
    End Period Cash Flow5,605,000USD20,541,000USD27,225,000USD40,740,000USD130,426,000USD15,583,000USD23,636,000USD38,288,000USD
    Other Cashflows From Investing Activities2,500,000USD————-4,415,000USD-85,000USD-188,000USD
    Other Cashflows From Financing Activities9,765,000USD-8,586,000USD-6,537,000USD-4,472,000USD-5,299,000USD-2,742,000USD143,000USD946,000USD
    Unclassified Financing Cash Flow-15,352,000USD———34,525,000USD64,932,000USD——
    Unclassified Investing Cash Flow——11,470,000USD——4,415,000USD——
    Change To Liabilities———4,965,000USD1,000,000USD60,000USD-1,873,000USD-376,000USD
    Net Borrowings———0USD891,000USD-38,987,000USD-6,104,000USD21,551,000USD
    Sale Purchase Of Stock———300,000USD158,697,000USD68,000USD143,000USD42,684,000USD
    Cash And Cash Equivalents Changes———-89,686,000USD114,027,000USD-7,390,000USD-14,652,000USD12,250,000USD
    Unclassified Operating Cash Flow———1,402,000USD————
    Change To Inventory——————1,873,000USD-49,925,000USD
    Dividends Paid———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2022Yearly · 2022-12-31ProductContra Revenue-116,000USD0001108205-23-000023
    FY 2022Yearly · 2022-12-31ProductGross Royalty Revenue10,278,000USD0001108205-23-000023
    FY 2022Yearly · 2022-12-31ProductOther Revenue0USD0001108205-23-000023
    Q4 2022Quarterly · 2022-12-31ProductContra Revenue-14,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31ProductGross Royalty Revenue2,901,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31ProductOther Revenue0USDLegacy provider
    Q3 2022Quarterly · 2022-09-30ProductContra Revenue-18,000USD0001108205-22-000023
    Q3 2022Quarterly · 2022-09-30ProductGross Royalty Revenue2,843,000USD0001108205-22-000023
    Q3 2022Quarterly · 2022-09-30ProductOther Revenue0USD0001108205-22-000023
    Q2 2022Quarterly · 2022-06-30ProductContra Revenue-81,000USD0001108205-22-000009
    Q2 2022Quarterly · 2022-06-30ProductGross Royalty Revenue2,474,000USD0001108205-22-000009
    Q2 2022Quarterly · 2022-06-30ProductOther Revenue0USD0001108205-22-000009
    Q1 2022Quarterly · 2022-03-31ProductContra Revenue-3,000USD0001108205-22-000005
    Q1 2022Quarterly · 2022-03-31ProductGross Royalty Revenue2,060,000USD0001108205-22-000005
    FY 2021Yearly · 2021-12-31ProductContra Revenue-101,000USD0001108205-23-000023
    FY 2021Yearly · 2021-12-31ProductGross Royalty Revenue10,749,000USD0001108205-23-000023
    FY 2021Yearly · 2021-12-31ProductOther Revenue1,000USD0001108205-23-000023
    Q4 2021Quarterly · 2021-12-31ProductContra Revenue-21,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31ProductGross Royalty Revenue3,156,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31ProductOther Revenue0USDLegacy provider
    Q3 2021Quarterly · 2021-09-30ProductContra Revenue-19,000USD0001108205-22-000023
    Q3 2021Quarterly · 2021-09-30ProductGross Royalty Revenue3,058,000USD0001108205-22-000023
    Q3 2021Quarterly · 2021-09-30ProductOther Revenue0USD0001108205-22-000023
    Q2 2021Quarterly · 2021-06-30ProductContra Revenue-63,000USD0001108205-22-000009
    Q2 2021Quarterly · 2021-06-30ProductGross Royalty Revenue2,348,000USD0001108205-22-000009
    Q2 2021Quarterly · 2021-06-30ProductOther Revenue1,000USD0001108205-22-000009
    Q1 2021Quarterly · 2021-03-31ProductContra Revenue2,000USD0001108205-21-000006
    Q1 2021Quarterly · 2021-03-31ProductGross Royalty Revenue2,187,000USD0001108205-21-000006
    Q1 2021Quarterly · 2021-03-31ProductOther Revenue0USD0001108205-21-000006
    FY 2018Yearly · 2018-12-31ProductContra Revenue7,000USD0001108205-20-000003
    FY 2018Yearly · 2018-12-31ProductResearch And Development Net100,000USD0001108205-20-000003
    FY 2018Yearly · 2018-12-31ProductRoyalty10,421,000USD0001108205-20-000003
    FY 2017Yearly · 2017-12-31ProductReimbursable Researchand Development Adjustment49,000USD0001108205-19-000004
    FY 2017Yearly · 2017-12-31ProductRoyalty9,849,000USD0001108205-19-000004

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.